Patents-Review.com
ClassID:

21093 ⎘

A61K39/08 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Bacterial antigens Clostridium, e.g. Clostridium tetani

Recent Application in this class:
#1
20260151471
2026-06-04

VACCINE CONTAINING RBD2 OF CDTB COMPONENT FROM BINARY TOXIN CDT OF CLOSTRIDIOIDES DIFFICILE

 #2
20260115235
2026-04-30

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #3
20260102480
2026-04-16

DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE

 #4
20260014251
2026-01-15

COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

 #5
20250381258
2025-12-18

EPSILON TOXIN FROM CLOSTRIDIUM PERFRINGENS AS A VACCINE

 #6
20250375488
2025-12-11

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #7
20250360191
2025-11-27

ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF

 #8
20250312432
2025-10-09

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE

 #9
20250281597
2025-09-11

A VACCINE FOR THE PROTECTION OF PIGLETS AGAINST SWINE INFLUENZA A VIRUS INFECTION

 #10
20250277007
2025-09-04

CWP2 PROTEIN AS AN EFFECTIVE VACCINE AGAINST CLOSTRIDIOIDES DIFFICILE INFECTION

 #11
20250255957
2025-08-14

VACCINES HAVING AN ANTIGEN AND INTERLEUKIN-21 AS AN ADJUVANT

 #12
20250213667
2025-07-03

CLOSTRIDIUM DIFFICILE VACCINE

 #13
20250205326
2025-06-26

COMPOSITIONS OF VACCINES AGAINST CLOSTRIDIAL DERMATITIS AND METHODS OF USE THEREOF

 #14
20250179526
2025-06-05

ADENOVIRUS VECTORS AND METHODS FOR USING ADENOVIRUS VECTORS

 #15
20250161437
2025-05-22

METHODS AND PARTICLES FOR MODULATING AN IMMUNE RESPONSE

 #16
20250154286
2025-05-15

ANTI-PCSK9 ANTIBODIES

 #17
20250114448
2025-04-10

SAPONIN-BASED ADJUVANTS AND VACCINES

 #18
20250108103
2025-04-03

OIL-BASED ADJUVANTS

 #19
20250099565
2025-03-27

CLOSTRIDIUM CHAUVOEI VACCINE AND METHOD OF MAKING

 #20
20250025551
2025-01-23

COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE

 #21
20240398957
2024-12-05

ADDITIVES FOR PROTEIN FORMULATIONS TO IMPROVE THERMAL STABILITY

 #22
20240390470
2024-11-28

Non-Toxin Antigens For Clostridioides Difficile Vaccine

 #23
20240382571
2024-11-21

Albumin-Free Botulinum Toxin Formulations

 #24
20240366755
2024-11-07

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS

 #25
20240358811
2024-10-31

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

 #26
20240350598
2024-10-24

Anti-Abeta Therapeutic Vaccines

 #27
20240335519
2024-10-10

OSTRICH ANTIBODY FOR BACTERIAL INFECTIOUS DISEASES

 #28
20240327443
2024-10-03

TRITERPENE SAPONIN ANALOGUES

 #29
20240307463
2024-09-19

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #30
20240307462
2024-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

 #31
20240261383
2024-08-08

RECOMBINANT FUSION PROTEIN VACCINE CONTAINING CLOSTRIDIOIDES DIFFICILE FLIC AND FLID

 #32
20240226262
2024-07-11

Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins

 #33
20240216495
2024-07-04

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE

 #34
20240197868
2024-06-20

IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS

 #35
20240197863
2024-06-20

Liquid six combined vaccine composition

 #36
20240189410
2024-06-13

IMMUNOGENIC COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE

 #37
20240139332
2024-05-02

Modified Clostridial Neurotoxins as Vaccine and Conjugate Vaccine Platforms

 #38
20240131137
2024-04-25

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

 #39
20240115696
2024-04-11

ANTIBODIES TO TIGIT

 #40
20240000913
2024-01-04

Oil-based adjuvants

 #41
20230391835
2023-12-07

COMPOSITIONS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN AND METHODS THEREOF

 #42
20230357300
2023-11-09

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

 #43
20230340153
2023-10-26

Anti-PCSK9 antibodies

 #44
20230279428
2023-09-07

ADENOVIRUS VECTORS AND METHODS FOR USING ADENOVIRUS VECTORS

 #45
20230277638
2023-09-07

Southern cattle tick vaccine product

 #46
20230219991
2023-07-13

Triterpene saponin analogues

 #47
20230218735
2023-07-13

IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE AND METHODS THEREOF

 #48
20230173052
2023-06-08

ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF

 #49
20230165950
2023-06-01

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

 #50
20230165949
2023-06-01

CLOSTRIDIUM DIFFICILE ANTIGENS

 #51
20230142894
2023-05-11

Vaccine for prevention of necrotic enteritis in poultry

 #52
20230083448
2023-03-16

COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME

 #53
20230072809
2023-03-09

ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND PERTUSSIS

 #54
20230033858
2023-02-02

DIRECT APPLICATION SYSTEM AND METHOD FOR THE DELIVERY OF BIOACTIVE COMPOSITIONS AND FORMULATIONS

 #55
20220347295
2022-11-03

Vaccine delivery method

 #56
20220313809
2022-10-06

CLOSTRIDIOIDES DIFFICILE TCDB VARIANTS, VACCINES AND METHODS OF USE

 #57
20220305131
2022-09-29

MODIFIED VIRUS-LIKE PARTICLES OF CMV

 #58
20220280629
2022-09-08

ANTIMICROBIAL VACCINE COMPOSITIONS

 #59
20220249656
2022-08-11

NANOPARTICLES FOR USE IN REDIRECTION AGAINST THE TUMOUR OF A NON-TUMOUR SPECIFIC IMMUNE RESPONSE, BASED ON A PRE-EXISTING IMMUNITY

 #60
20220226455
2022-07-21

VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY

 #61
20220184198
2022-06-16

COMPOSITION FOR MUCOSAL ADMINISTRATION TO AVIANS

 #62
20220160859
2022-05-26

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE

 #63
20220144924
2022-05-12

EPITOPES OF CLOSTRIDIUM DIFFICILE TOXINS A AND B AND USES THEREOF

 #64
20220125901
2022-04-28

TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA

 #65
20220096568
2022-03-31

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #66
20220062401
2022-03-03

VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE

 #67
20220062400
2022-03-03

Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect

 #68
20220054615
2022-02-24

PERTUSSIS BOOSTER VACCINE

 #69
20220049271
2022-02-17

Adenovirus vectors and methods for using adenovirus vectors

 #70
20220040282
2022-02-10

LOW CONTAMINANT COMPOSITIONS

 #71
20220031827
2022-02-03

Tetanus toxoid and CCL3 improve DC vaccines

 #72
20220031826
2022-02-03

Vaccine for the prevention and treatment of C. difficile infections and the use thereof

 #73
20220023406
2022-01-27

COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION

 #74
20220000998
2022-01-06

BI-SPECIFIC CONJUGATES

 #75
20220000779
2022-01-06

IMMUNOGENIC COMPOSITIONS

 #76
20210401962
2021-12-30

Vaccine for prevention of necrotic enteritis in poultry

 #77
20210393761
2021-12-23

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

 #78
20210379186
2021-12-09

ADDITIVES FOR PROTEIN FORMULATIONS TO IMPROVE THERMAL STABILITY

 #79
20210369840
2021-12-02

METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS

 #80
20210369831
2021-12-02

CLOSTRIDIUM DIFFICILE MULTI-COMPONENT VACCINE

 #81
20210369830
2021-12-02

CLOSTRIDIUM DIFFICILE ANTIGENS

 #82
20210353733
2021-11-18

VACCINE AND ANTIBODY AGAINST CLOSTRIDIOIDES DIFFICILE TOXIN

 #83
20210330766
2021-10-28

Albumin-free botulinum toxin formulations

 #84
20210308214
2021-10-07

COMPOSITIONS OF STING VARIANTS, COMBINATIONS THEREOF, AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE AGAINST INFECTIONS, DISEASES, AND DISORDERS

 #85
20210300970
2021-09-30

COVID-19 VACCINE

 #86
20210299237
2021-09-30

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

 #87
20210284955
2021-09-16

Induction of protective immunity against antigens

 #88
20210283236
2021-09-16

Low contaminant compositions

 #89
20210275648
2021-09-09

Southern cattle tick vaccine product

 #90
20210269511
2021-09-02

ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF

 #91
20210253735
2021-08-19

ANTI-PCSK9 ANTIBODIES

 #92
20210252124
2021-08-19

Combination vaccine

 #93
20210244808
2021-08-12

METHODS FOR INHIBITING BIOFILM FORMATION

 #94
20210236631
2021-08-05

Vaccines having an antigen and interleukin-21 as an adjuvant

 #95
20210236617
2021-08-05

Poultry vaccine for clostridium perfringens

 #96
20210213129
2021-07-15

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

 #97
20210205431
2021-07-08

Compositions comprising recombinant probiotic bacteria and methods of use thereof

 #98
20210170013
2021-06-10

Oil-based adjuvants

 #99
20210170009
2021-06-10

Intestinal bacteria and application thereof

 #100
20210145956
2021-05-20

Compositions and methods for immunizing against

#101
20210145955
2021-05-20

CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE

 #102
20210121554
2021-04-29

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

 #103
20210093700
2021-04-01

Anti-abeta therapeutic vaccines

 #104
20210069258
2021-03-11

COMPOSITIONS COMPRISING BACTERIAL STRAINS

 #105
20210052715
2021-02-25

Immunomodulatory minicells and methods of use

 #106
20210015916
2021-01-21

Vaccine delivery method

 #107
20210002316
2021-01-07

TRITERPENE SAPONIN ANALOGUES

 #108
20210000947
2021-01-07

Mucosal adjuvants and delivery systems

 #109
20200405836
2020-12-31

Epsilon toxin from clostridium perfringens as a vaccine

 #110
20200397883
2020-12-24

Combination product for use in tumor vaccination

 #111
20200384120
2020-12-10

Modified clostridial neurotoxins as vaccines and conjugate vaccine platforms

 #112
20200384097
2020-12-10

COMPOSITION

 #113
20200384091
2020-12-10

METHOD OF TREATING DEPRESSION

 #114
20200377620
2020-12-03

CLOSTRIDIUM PERFRINGENS SURFACE GLYCANS AND USES THEREOF

 #115
20200368339
2020-11-26

Induction of protective immunity against antigens

 #116
20200353063
2020-11-12

Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea

 #117
20200338185
2020-10-29

OSTRICH ANTIBODY FOR BACTERIAL INFECTIOUS DISEASES

 #118
20200331949
2020-10-22

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

 #119
20200306354
2020-10-01

Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea

 #120
20200306298
2020-10-01

Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

 #121
20200297844
2020-09-24

Antibodies to TIGIT

 #122
20200297825
2020-09-24

Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

 #123
20200282048
2020-09-10

Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

 #124
20200277675
2020-09-03

BIOMARKERS FOR PREDICTING RESPONSE TO CLOSTRIDIUM DIFFICILE

 #125
20200254082
2020-08-13

Non-toxigenic spores for use in oral vaccination

 #126
20200254081
2020-08-13

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE

 #127
20200254079
2020-08-13

Compositions and methods for the induction of CD8+ T-cells

 #128
20200246399
2020-08-06

Composition for inducing proliferation or accumulation of regulatory T cells

 #129
20200239509
2020-07-30

Triterpene saponin analogues

 #130
20200237888
2020-07-30

COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF

 #131
20200230223
2020-07-23

Immunogenic proteins against

#132
20200222521
2020-07-16

Vaccine for prevention of necrotic enteritis in poultry

 #133
20200188500
2020-06-18

Vaccine comprising toxoids

 #134
20200155699
2020-05-21

Modified virus-like particles of CMV

 #135
20200138918
2020-05-07

Methods of treating abnormalities of the first metatarsophalangeal joint of the foot

 #136
20200123210
2020-04-23

IMMUNOGENIC PREPARATIONS AND METHODS AGAINST CLOSTRIDIUM DIFFICILE INFECTION

 #137
20200113991
2020-04-16

Compositions and Methods for Immunizing Against C. Difficile

 #138
20200095290
2020-03-26

Compositions relating to a mutant clostridium difficile toxin and methods thereof

 #139
20200093913
2020-03-26

Vaccine against necrotic enteritis in poultry

 #140
20200093871
2020-03-26

Compositions and methods for the induction of CD8+ T-cells

 #141
20200085940
2020-03-19

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

 #142
20200054042
2020-02-20

bacteriophage Clo-PEP-2 and use for inhibiting proliferation of same

 #143
20200000911
2020-01-02

IMMUNOGENIC COMPOSITION

 #144
20190382717
2019-12-19

Induction of protective immunity against antigens

 #145
20190381157
2019-12-19

METHODS OF IMMUNE MODULATION AGAINST FOREIGN AND/OR AUTO ANTIGENS

 #146
20190381111
2019-12-19

Compositions and methods for the induction of CD8+ T-cells

 #147
20190364398
2019-11-28

Vaccine monitoring system

 #148
20190336593
2019-11-07

Clostridium difficile immunogenic compositions and methods of use

 #149
20190328859
2019-10-31

CLOSTRIDIUM DIFFICILE ANTIGENS

 #150
20190307875
2019-10-10

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

 #151
20190307867
2019-10-10

Anti-abeta therapeutic vaccines

 #152
20190298854
2019-10-03

DRUG DELIVERY PARTICLES

 #153
20190298822
2019-10-03

Immunogenic composition

 #154
20190290747
2019-09-26

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

 #155
20190290740
2019-09-26

Albumin-free botulinum toxin formulations

 #156
20190282635
2019-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

 #157
20190282634
2019-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

 #158
20190275125
2019-09-12

ABETA VARIANTS, ASSAY, METHOD AND TREATMENT OF ALZHEIMER'S DISEASE

 #159
20190270779
2019-09-05

Re-directed immunotherapy

 #160
20190269775
2019-09-05

COMPOSITIONS AND METHODS OF TREATING CANCER

 #161
20190241923
2019-08-08

Method for the production of protein complexes and vaccine compositions comprising the same

 #162
20190240364
2019-08-08

Air pollution abatement and crop growth stimulation technology

 #163
20190231869
2019-08-01

Mucosal adjuvants and delivery systems

 #164
20190224224
2019-07-25

Guanosine as an Immune Potentiator Mediated through Toll Receptors

 #165
20190202873
2019-07-04

Compositions relating to a mutant clostridium difficile toxin and methods thereof

 #166
20190183986
2019-06-20

CELL MEMBRANE TRANSLOCATION OF REGULATED SNARE INHIBITORS, COMPOSITIONS THEREFOR, AND METHODS FOR TREATMENT OF DISEASE

 #167
20190183802
2019-06-20

ACTIVE SELF-HEALING BIOMATERIAL SYSTEM

 #168
20190183790
2019-06-20

SINGLE DOSE NON-ADJUVANTED CUTANEOUS TETANUS VACCINE AND USES THEREOF

 #169
20190167778
2019-06-06

Immunomodulatory minicells and methods of use

 #170
20190167600
2019-06-06

Biomolecule preservation

 #171
20190142936
2019-05-16

Dry solid aluminum adjuvant-containing vaccines and related methods thereof

 #172
20190135941
2019-05-09

Anti-PCSK9 antibodies

 #173
20190134179
2019-05-09

COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MOLECULES DERIVED FROM MICROBIOTA FOR TREATMENT OF DISEASE

 #174
20190099479
2019-04-04

Recombinant HCMV and RHCMV vectors and uses thereof

 #175
20190076518
2019-03-14

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

 #176
20190070273
2019-03-07

Methods of treating abnormalities of the first metatarsophalangeal joint of the foot

 #177
20190060447
2019-02-28

Vaccines having an antigen and interleukin-21 as an adjuvant

 #178
20190046592
2019-02-14

Composition for inducing proliferation or accumulation of regulatory T cells

 #179
20190038737
2019-02-07

Oil-based adjuvants

 #180
20190030093
2019-01-31

Composition for inducing proliferation or accumulation of regulatory T cells

 #181
20190015502
2019-01-17

Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants

 #182
20180360947
2018-12-20

Compositions and methods for stabilization of active agents

 #183
20180344834
2018-12-06

Immunogenic proteins against clostridium difficile

 #184
20180339034
2018-11-29

Intestinal bacteria butyribacterintestini and application thereof

 #185
20180327436
2018-11-15

TRITERPENE SAPONIN ANALOGUES

 #186
20180311333
2018-11-01

Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect

 #187
20180258145
2018-09-13

Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein

 #188
20180256697
2018-09-13

Non-toxigenic spores for use in oral vaccination

 #189
20180256689
2018-09-13

Methods of treating abnormalities of the first metatarsophalangeal joint of the foot

 #190
20180250346
2018-09-06

Compositions comprising bacterial strains

 #191
20180244731
2018-08-30

Compositions and methods for treatment of pain

 #192
20180243395
2018-08-30

Injectable vaccines against multiple meningococcal serogroups

 #193
20180236054
2018-08-23

Tetanus toxoid and CCL3 improve DC vaccines

 #194
20180236050
2018-08-23

Method of treating depression

 #195
20180214557
2018-08-02

Carrier molecule compositions and related methods

 #196
20180208643
2018-07-26

ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF

 #197
20180153981
2018-06-07

Composition for inducing proliferation or accumulation of regulatory T cells

 #198
20180147266
2018-05-31

Highly pure neurotoxic component of a botulinum toxin and uses thereof

 #199
20180110849
2018-04-26

METHODS FOR IMMUNIZING AGAINST CLOSTRIDIUM DIFFICILE

 #200
20180104324
2018-04-19

Immunogenic composition

 #201
20180104320
2018-04-19

Treatment of cancer using recall antigens delivered by attenuated bacteria

 #202
20180085458
2018-03-29

METHODS FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION AND ASSOCIATED DISEASE

 #203
20180078632
2018-03-22

VHH constructs for diverting an immune response

 #204
20180073089
2018-03-15

Chimeric polypeptides

 #205
20180066225
2018-03-08

Method of preparing bacterial ghosts from gram-positive bacteria by hydrochloric acid treatment

 #206
20180064806
2018-03-08

Immunogenic composition

 #207
20180043005
2018-02-15

IMMUNOGENIC COMPOSITION COMPRISING ELEMENTS OF C. DIFFICILE CDTB AND/OR CDTA PROTEINS

 #208
20180028637
2018-02-01

Toxoid, Compositions and Related Methods

 #209
20180022784
2018-01-25

Clostridium difficile toxins a and/or B antigen and epitope antibody, and pharmaceutical uses thereof

 #210
20180008667
2018-01-11

Cell penetrating antibodies

 #211
20180000921
2018-01-04

Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease

 #212
20180000920
2018-01-04

Pharmaceutical compositions containing toxoids A and B

 #213
20180000919
2018-01-04

Compositions comprising recombinant probiotic bacteria and methods of use thereof

 #214
20170362309
2017-12-21

Nucleotide sequences, vectors and host cells

 #215
20170340719
2017-11-30

Immunogenic composition

 #216
20170319671
2017-11-09

Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

 #217
20170313749
2017-11-02

Compositions relating to a mutant toxin and methods thereof

 #218
20170312371
2017-11-02

Modified virus-like particles of CMV

 #219
20170304423
2017-10-26

Compositions and Methods for Immunizing Against C. Difficile

 #220
20170304374
2017-10-26

CAPSULE FOR THE ORAL ADMINISTRATION OF BIOPHARMACEUTICALS

 #221
20170258899
2017-09-14

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

 #222
20170258889
2017-09-14

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

 #223
20170247421
2017-08-31

Nucleotide sequences, vectors and host cells

 #224
20170246283
2017-08-31

Composition for inducing proliferation or accumulation of regulatory T cells

 #225
20170246266
2017-08-31

Cell penetrating peptide, conjugate thereof with botulinum toxin, and use thereof

 #226
20170239340
2017-08-24

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

 #227
20170232100
2017-08-17

Vaccines having an antigen and interleukin-21 as an adjuvant

 #228
20170218031
2017-08-03

CLOSTRIDIUM DIFFICILE IMMUNOGENIC COMPOSITION

 #229
20170212113
2017-07-27

Predictive value of -specific immune response for recurrence and disease outcome

 #230
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #231
20170196970
2017-07-13

Adjuvant for mucosal vaccine

 #232
20170143823
2017-05-25

Mucosal adjuvants and delivery systems

 #233
20170143815
2017-05-25

Immunomodulatory minicells and methods of use

 #234
20170143775
2017-05-25

Compositions comprising bacterial strains

 #235
20170135958
2017-05-18

Use of vitelline protein B as a microencapsulating additive

 #236
20170112915
2017-04-27

Composition for inducing proliferation or accumulation of regulatory T cells

 #237
20170093100
2017-03-30

Movable wall panel system with electrical connections

 #238
20170087197
2017-03-30

Composition for inducing proliferation or accumulation of regulatory T cells

 #239
20170072030
2017-03-16

Neurotoxins exhibiting shortened biological activity

 #240
20170065714
2017-03-09

Immunogenic composition

 #241
20170065702
2017-03-09

METHODS OF MODULATING AN IMMUNE RESPONSE

 #242
20170051023
2017-02-23

Vaccine

 #243
20170049877
2017-02-23

West Nile Virus vaccine

 #244
20170049866
2017-02-23

Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease

 #245
20170042920
2017-02-16

Guanosine as an immune potentiator mediated through toll receptors

 #246
20170008937
2017-01-12

Compositions and methods for treating or preventing infection

 #247
20170007691
2017-01-12

Composition for inducing proliferation or accumulation of regulatory T cells

 #248
20160354457
2016-12-08

Injectable vaccines against multiple meningococcal serogroups

 #249
20160339095
2016-11-24

Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

 #250
20160326222
2016-11-10

CLOSTRIDIUM DIFFICILE VACCINE

 #251
20160319037
2016-11-03

antigens

 #252
20160317640
2016-11-03

Pharmaceutical compositions containing toxoids A and B

 #253
20160317638
2016-11-03

Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea

 #254
20160310587
2016-10-27

COMPOSITION

 #255
20160310412
2016-10-27

MICRONEEDLE

 #256
20160287698
2016-10-06

Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants

 #257
20160287689
2016-10-06

IMMUNIZATION AGAINST CLOSTRIDIUM DIFFICILE DISEASE

 #258
20160271240
2016-09-22

Tetanus toxoid and CCL3 improve DC vaccines

 #259
20160263021
2016-09-15

Single dose non-adjuvanted cutaneous tetanus vaccine and uses thereof

 #260
20160256544
2016-09-08

Adjuvanted vaccines for in ovo avian vaccination

 #261
20160256532
2016-09-08

Albumin-free botulinum toxin formulations

 #262
20160235831
2016-08-18

Process for stabilizing an adjuvant containing vaccine composition

 #263
20160228540
2016-08-11

Nasal mucosal vaccine composition

 #264
20160213776
2016-07-28

Adsorption of immunopotentiators to insoluble metal salts

 #265
20160193327
2016-07-07

Mucosal vaccine composition

 #266
20160193324
2016-07-07

Methods of immunization with varicella zoster virus antigen

 #267
20160193322
2016-07-07

COMBINATION IMMUNOGENIC COMPOSITIONS

 #268
20160193318
2016-07-07

Vaccine

 #269
20160175407
2016-06-23

Highly pure neurotoxic component of a botulinum toxin, process for preparing same, and uses thereof

 #270
20160166672
2016-06-16

Atoxic recombinant holotoxins of Clostridium difficile as immunogens

 #271
20160166671
2016-06-16

Clostridium Difficile Compositions and Methods of Use

 #272
20160159867
2016-06-09

Nucleotide sequences, vectors and host cells

 #273
20160144023
2016-05-26

DRY SOLID ALUMINUM ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF

 #274
20160144014
2016-05-26

Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease

 #275
20160136256
2016-05-19

Polysaccharide-protein conjugate vaccines

 #276
20160120968
2016-05-05

Compositions and methods for immunizing against C. difficile

 #277
20160114027
2016-04-28

Recombinant HCMV and RHCMV vectors and uses thereof

 #278
20160106862
2016-04-21

Re-directed immunotherapy

 #279
20160090401
2016-03-31

Self-assembling peptide cages from coiled-coil peptide modules

 #280
20160074496
2016-03-17

Clostridium difficile vaccine and methods of use

 #281
20160067324
2016-03-10

Vaccine formulation for ocular immunization

 #282
20160052977
2016-02-25

Toxins in type A

#283
20160045591
2016-02-18

Vaccine and therapeutic delivery system

 #284
20160045586
2016-02-18

Toxoid, Compositions and Related Methods

 #285
20160045585
2016-02-18

Formulations

 #286
20160039889
2016-02-11

Mono or multivalent botulinum neurotoxin based vaccine using the heavy chain from serotypes of

#287
20160030542
2016-02-04

Toxoid, Compositions and Related Methods

 #288
20160030511
2016-02-04

Neurotoxins exhibiting shortened biological activity

 #289
20160030349
2016-02-04

NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF

 #290
20160024192
2016-01-28

MOLECULAR CONJUGATES COMPRISING HUMAN MONOCLONAL ANTIBODIES TO DENDRITIC CELLS

 #291
20160022793
2016-01-28

Compositions for treatment and/or prevention of autoimmune disorders

 #292
20150368320
2015-12-24

Polyclonal antibodies against and uses thereof

 #293
20150344531
2015-12-03

MEDICAMENT FOR LCT POISONING

 #294
20150343049
2015-12-03

Vaccine

 #295
20150343048
2015-12-03

Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for associated disease (CDAD)

 #296
20150322176
2015-11-12

NOVEL POLYSACCHARIDE IMMUNOGENS FROM CLOSTRIDIUM BOLTEAE ISOLATED FROM AUTISTIC SUBJECTS AND METHODS AND USES THEREOF

 #297
20150320852
2015-11-12

CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

 #298
20150315248
2015-11-05

Clostridium difficile polypeptides as vaccine

 #299
20150313991
2015-11-05

VACCINATION ADJUVANT, PREPARATION AND VACCINES CONTAINING THE SAME

 #300
20150313985
2015-11-05

Immunogenic composition comprising elements of C. difficile CDTb and/or CDTa proteins